SIMILAR PATTERNS OF AMINO ACIDS FOR 2H42_C_VIAC903_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ci9 PROTEIN
(CARBOXYLESTERASE)

(Burkholderia
gladioli) 		PF00144
(Beta-lactamase) 		5 LEU A 302
LEU A  96
ALA A  98
ILE A 121
LEU A 207
 None
 0.97A 2h42C-1ci9A:
0.0		 2h42C-1ci9A:
20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ff9 SACCHAROPINE
REDUCTASE

(Magnaporthe
grisea) 		PF03435
(Sacchrp_dh_NADP)
PF16653
(Sacchrp_dh_C) 		5 ILE A 442
VAL A 405
ALA A 406
PHE A 409
ILE A 123
 None
 0.88A 2h42C-1ff9A:
0.0		 2h42C-1ff9A:
21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ij5 PLASMODIAL SPECIFIC
LAV1-2 PROTEIN

(Physarum
polycephalum) 		PF13202
(EF-hand_5) 		5 LEU A 347
ALA A 314
ILE A 316
ILE A 187
PHE A 352
 None
 0.97A 2h42C-1ij5A:
0.1		 2h42C-1ij5A:
21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j32 ASPARTATE
AMINOTRANSFERASE

(Phormidium
lapideum) 		PF00155
(Aminotran_1_2) 		5 LEU A 313
LEU A 384
VAL A 348
ALA A 349
PHE A 338
 None
 1.03A 2h42C-1j32A:
0.0		 2h42C-1j32A:
20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1j32 ASPARTATE
AMINOTRANSFERASE

(Phormidium
lapideum) 		PF00155
(Aminotran_1_2) 		5 LEU A 384
VAL A 348
ALA A 349
ILE A  18
PHE A 338
 None
 1.12A 2h42C-1j32A:
0.0		 2h42C-1j32A:
20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1kve SMK TOXIN

(Millerozyma
farinosa) 		no annotation 5 LEU A  21
LEU A  62
ALA A  60
ILE A  61
PHE B 205
 None
 0.85A 2h42C-1kveA:
undetectable		 2h42C-1kveA:
11.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lf9 GLUCOAMYLASE

(Thermoanaerobacterium
thermosaccharolyticum) 		PF00723
(Glyco_hydro_15)
PF09137
(Glucodextran_N) 		5 ALA A 319
ILE A 318
VAL A 348
ALA A 349
PHE A 352
 ACR  A 700 (-3.2A)
None
None
None
None
 0.88A 2h42C-1lf9A:
1.0		 2h42C-1lf9A:
19.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1soj CGMP-INHIBITED
3',5'-CYCLIC
PHOSPHODIESTERASE B

(Homo sapiens) 		PF00233
(PDEase_I) 		5 TYR A 736
LEU A 895
PHE A 959
GLN A 988
PHE A 991
 IBM  A2111 (-4.5A)
None
None
IBM  A2111 (-3.3A)
IBM  A2111 (-3.6A)
 0.41A 2h42C-1sojA:
34.1		 2h42C-1sojA:
24.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zkl HIGH-AFFINITY
CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 7A

(Homo sapiens) 		PF00233
(PDEase_I) 		5 TYR A 211
VAL A 380
ILE A 409
GLN A 413
PHE A 416
 IBM  A 503 (-4.6A)
IBM  A 503 (-4.7A)
None
IBM  A 503 (-3.0A)
IBM  A 503 (-3.4A)
 0.72A 2h42C-1zklA:
34.9		 2h42C-1zklA:
28.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zkl HIGH-AFFINITY
CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 7A

(Homo sapiens) 		PF00233
(PDEase_I) 		5 TYR A 211
VAL A 380
PHE A 384
GLN A 413
PHE A 416
 IBM  A 503 (-4.6A)
IBM  A 503 (-4.7A)
IBM  A 503 (-4.5A)
IBM  A 503 (-3.0A)
IBM  A 503 (-3.4A)
 0.54A 2h42C-1zklA:
34.9		 2h42C-1zklA:
28.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dsj PYRIMIDINE-NUCLEOSID
E (THYMIDINE)
PHOSPHORYLASE

(Thermus
thermophilus) 		PF00591
(Glycos_transf_3)
PF02885
(Glycos_trans_3N)
PF07831
(PYNP_C) 		5 LEU A 159
ALA A 157
ALA A 180
LEU A  50
ILE A 223
 None
 1.04A 2h42C-2dsjA:
0.0		 2h42C-2dsjA:
22.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2l1n UNCHARACTERIZED
PROTEIN

(Synechococcus
elongatus) 		PF08853
(DUF1823) 		5 LEU A  26
ALA A  30
ALA A 113
LEU A  83
ILE A  75
 None
 1.11A 2h42C-2l1nA:
0.0		 2h42C-2l1nA:
15.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q1z ANTI-SIGMA FACTOR
CHRR,
TRANSCRIPTIONAL
ACTIVATOR CHRR

(Rhodobacter
sphaeroides) 		PF12973
(Cupin_7)
PF13490
(zf-HC2) 		5 LEU B 102
LEU B 129
ALA B 127
LEU B  34
ILE B 168
 None
 1.01A 2h42C-2q1zB:
undetectable		 2h42C-2q1zB:
20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qyk CYCLIC AMP-SPECIFIC
PHOSPHODIESTERASE
HSPDE4A10

(Homo sapiens) 		PF00233
(PDEase_I) 		5 TYR A 371
LEU A 531
PHE A 552
GLN A 581
PHE A 584
 NPV  A   3 (-4.4A)
None
NPV  A   3 (-4.8A)
NPV  A   3 (-3.1A)
NPV  A   3 (-3.3A)
 0.42A 2h42C-2qykA:
35.9		 2h42C-2qykA:
29.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2r8q CLASS I
PHOSPHODIESTERASE
PDEB1

(Leishmania
major) 		PF00233
(PDEase_I) 		5 TYR A 680
VAL A 853
PHE A 857
GLN A 887
PHE A 890
 IBM  A   3 ( 4.7A)
IBM  A   3 ( 4.8A)
IBM  A   3 (-4.9A)
IBM  A   3 (-3.3A)
IBM  A   3 (-3.6A)
 0.56A 2h42C-2r8qA:
38.1		 2h42C-2r8qA:
31.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2yd3 RECEPTOR-TYPE
TYROSINE-PROTEIN
PHOSPHATASE S

(Homo sapiens) 		PF07679
(I-set) 		5 LEU A  96
LEU A 122
ALA A 213
PHE A 134
LEU A 130
 None
 1.00A 2h42C-2yd3A:
undetectable		 2h42C-2yd3A:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3a9v 4-COUMARATE--COA
LIGASE

(Populus
tomentosa) 		PF00501
(AMP-binding)
PF13193
(AMP-binding_C) 		5 LEU A 309
LEU A 326
ALA A 324
LEU A 230
ILE A 226
 None
 0.96A 2h42C-3a9vA:
undetectable		 2h42C-3a9vA:
21.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3b2r CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE

(Homo sapiens) 		PF00233
(PDEase_I) 		11 TYR A 612
LEU A 725
LEU A 765
ALA A 767
ILE A 768
VAL A 782
ALA A 783
PHE A 786
ILE A 813
GLN A 817
PHE A 820
 VDN  A   1 (-4.8A)
None
VDN  A   1 ( 4.7A)
VDN  A   1 ( 3.8A)
VDN  A   1 (-4.5A)
VDN  A   1 ( 4.7A)
VDN  A   1 ( 4.0A)
None
VDN  A   1 ( 4.2A)
VDN  A   1 (-3.0A)
VDN  A   1 (-3.6A)
 0.41A 2h42C-3b2rA:
46.6		 2h42C-3b2rA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3bjc CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE

(Homo sapiens) 		PF00233
(PDEase_I) 		11 TYR A 612
LEU A 725
LEU A 765
ALA A 767
ILE A 768
VAL A 782
ALA A 783
PHE A 786
ILE A 813
GLN A 817
PHE A 820
 None
None
WAN  A 901 ( 4.7A)
WAN  A 901 ( 3.9A)
WAN  A 901 ( 4.9A)
WAN  A 901 ( 4.9A)
WAN  A 901 (-3.6A)
WAN  A 901 (-4.8A)
WAN  A 901 ( 4.3A)
WAN  A 901 (-3.1A)
WAN  A 901 (-3.7A)
 0.31A 2h42C-3bjcA:
48.1		 2h42C-3bjcA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dm0 MALTOSE-BINDING
PERIPLASMIC PROTEIN
FUSED WITH RACK1

(Arabidopsis
thaliana;
Escherichia
coli) 		PF00400
(WD40)
PF01547
(SBP_bac_1) 		5 LEU A 262
ILE A 108
VAL A  97
LEU A  76
ILE A  79
 None
 0.92A 2h42C-3dm0A:
undetectable		 2h42C-3dm0A:
18.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fd3 CHROMOSOME
REPLICATION
INITIATION INHIBITOR
PROTEIN

(Agrobacterium
fabrum) 		PF03466
(LysR_substrate) 		5 LEU A 303
ALA A 146
ILE A 145
LEU A 181
PHE A 128
 None
PG4  A 321 ( 3.8A)
None
None
None
 0.97A 2h42C-3fd3A:
undetectable		 2h42C-3fd3A:
20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g4g CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D

(Homo sapiens) 		PF00233
(PDEase_I) 		5 TYR A 325
LEU A 485
PHE A 506
GLN A 535
PHE A 538
 None
None
D71  A 901 (-4.8A)
D71  A 901 (-3.1A)
D71  A 901 (-3.9A)
 0.60A 2h42C-3g4gA:
35.5		 2h42C-3g4gA:
26.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gyb TRANSCRIPTIONAL
REGULATORS
(LACI-FAMILY
TRANSCRIPTIONAL
REGULATORY PROTEIN)

(Corynebacterium
glutamicum) 		PF13377
(Peripla_BP_3) 		5 LEU A 282
LEU A 250
ALA A 252
ALA A 180
LEU A 171
 None
 0.98A 2h42C-3gybA:
undetectable		 2h42C-3gybA:
23.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ibj CGMP-DEPENDENT
3',5'-CYCLIC
PHOSPHODIESTERASE

(Homo sapiens) 		PF00233
(PDEase_I)
PF01590
(GAF)
PF13185
(GAF_2) 		5 TYR A 655
LEU A 770
LEU A 809
ILE A 855
PHE A 862
 None
 0.58A 2h42C-3ibjA:
38.5		 2h42C-3ibjA:
21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mi6 ALPHA-GALACTOSIDASE

(Lactobacillus
brevis) 		PF02065
(Melibiase)
PF16874
(Glyco_hydro_36C)
PF16875
(Glyco_hydro_36N) 		5 LEU A 184
ILE A 272
ALA A 236
LEU A 308
ILE A 194
 None
 1.02A 2h42C-3mi6A:
undetectable		 2h42C-3mi6A:
19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mp6 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,LINKER,SAGA-
ASSOCIATED FACTOR 29

(Escherichia
coli;
Saccharomyces
cerevisiae;
unidentified) 		PF07039
(DUF1325)
PF13416
(SBP_bac_8) 		5 LEU A1000
ILE A 846
VAL A 835
LEU A 814
ILE A 817
 None
 0.95A 2h42C-3mp6A:
undetectable		 2h42C-3mp6A:
21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n93 MALTOSE BINDING
PROTEIN-CRFR2 ALPHA

(Homo sapiens) 		PF02793
(HRM)
PF13416
(SBP_bac_8) 		5 LEU A-108
ILE A-262
VAL A-273
LEU A-294
ILE A-291
 None
 0.95A 2h42C-3n93A:
undetectable		 2h42C-3n93A:
19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n94 FUSION PROTEIN OF
MALTOSE-BINDING
PERIPLASMIC PROTEIN
AND PITUITARY
ADENYLATE CYCLASE 1
RECEPTOR-SHORT

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF13416
(SBP_bac_8) 		5 LEU A -86
ILE A-240
VAL A-251
LEU A-272
ILE A-269
 None
 0.92A 2h42C-3n94A:
undetectable		 2h42C-3n94A:
20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o57 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B

(Homo sapiens) 		PF00233
(PDEase_I) 		5 TYR A 233
LEU A 393
PHE A 414
GLN A 443
PHE A 446
 None
None
ZG2  A 506 (-4.4A)
ZG2  A 506 (-3.3A)
ZG2  A 506 (-3.6A)
 0.60A 2h42C-3o57A:
35.7		 2h42C-3o57A:
27.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oai MALTOSE-BINDING
PERIPLASMIC PROTEIN,
MYELIN PROTEIN P0

(Escherichia
coli;
Homo sapiens) 		PF07686
(V-set)
PF13416
(SBP_bac_8) 		5 LEU A 262
ILE A 108
VAL A  97
LEU A  76
ILE A  79
 None
 1.07A 2h42C-3oaiA:
undetectable		 2h42C-3oaiA:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oet ERYTHRONATE-4-PHOSPH
ATE DEHYDROGENASE

(Salmonella
enterica) 		PF00389
(2-Hacid_dh)
PF02826
(2-Hacid_dh_C)
PF11890
(DUF3410) 		5 LEU A 368
LEU A 138
ILE A 140
ALA A 102
ILE A 204
 None
 1.13A 2h42C-3oetA:
undetectable		 2h42C-3oetA:
21.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3osq MALTOSE-BINDING
PERIPLASMIC
PROTEIN,GREEN
FLUORESCENT PROTEIN

(Aequorea
victoria;
Escherichia
coli) 		PF01353
(GFP)
PF01547
(SBP_bac_1)
PF13416
(SBP_bac_8) 		5 LEU A 510
ILE A 108
VAL A  97
LEU A  76
ILE A  79
 None
 0.98A 2h42C-3osqA:
undetectable		 2h42C-3osqA:
18.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pxh RECEPTOR-TYPE
TYROSINE-PROTEIN
PHOSPHATASE F

(Mus musculus) 		PF07679
(I-set) 		5 LEU A  96
LEU A 122
ALA A 213
PHE A 134
LEU A 130
 None
 1.07A 2h42C-3pxhA:
undetectable		 2h42C-3pxhA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3py7 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,PAXILLIN
LD1,PROTEIN E6
CHIMERA

(Deltapapillomavirus
4;
Escherichia
coli;
Homo sapiens) 		PF00518
(E6)
PF01547
(SBP_bac_1) 		5 LEU A 263
ILE A 109
VAL A  98
LEU A  77
ILE A  80
 None
 1.07A 2h42C-3py7A:
undetectable		 2h42C-3py7A:
21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D

(Homo sapiens) 		PF00233
(PDEase_I) 		5 TYR A 159
LEU A 319
PHE A 340
GLN A 369
PHE A 372
 TYR  A 159 (-1.3A)
LEU  A 319 ( 0.6A)
PHE  A 340 (-1.3A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
 0.43A 2h42C-3sl5A:
35.9		 2h42C-3sl5A:
29.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ui7 CAMP AND
CAMP-INHIBITED CGMP
3',5'-CYCLIC
PHOSPHODIESTERASE
10A

(Homo sapiens) 		PF00233
(PDEase_I) 		6 TYR A 524
LEU A 635
LEU A 675
PHE A 696
GLN A 726
PHE A 729
 C1L  A   1 ( 4.8A)
None
C1L  A   1 (-4.3A)
C1L  A   1 ( 4.7A)
C1L  A   1 (-2.9A)
C1L  A   1 (-3.5A)
 0.47A 2h42C-3ui7A:
41.2		 2h42C-3ui7A:
39.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vd8 MALTOSE-BINDING
PERIPLASMIC PROTEIN,
INTERFERON-INDUCIBLE
PROTEIN AIM2

(Escherichia
coli;
Homo sapiens) 		PF02758
(PYRIN)
PF13416
(SBP_bac_8) 		5 LEU A 262
ILE A 108
VAL A  97
LEU A  76
ILE A  79
 None
 0.96A 2h42C-3vd8A:
undetectable		 2h42C-3vd8A:
21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w9u PUTATIVE LIPASE

(Proteus
mirabilis) 		PF00561
(Abhydrolase_1) 		5 LEU A 157
ALA A 135
ILE A 139
PHE A 226
ILE A 200
 None
 0.93A 2h42C-3w9uA:
undetectable		 2h42C-3w9uA:
20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wg1 GALACTOSIDE-BINDING
LECTIN

(Agrocybe
aegerita) 		PF00337
(Gal-bind_lectin) 		5 LEU A  50
VAL A  92
ALA A  93
PHE A  96
LEU A  36
 None
 1.09A 2h42C-3wg1A:
undetectable		 2h42C-3wg1A:
17.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b3n MALTOSE-BINDING
PERIPLASMIC PROTEIN,
TRIPARTITE
MOTIF-CONTAINING
PROTEIN 5

(Escherichia
coli;
Macaca mulatta) 		PF00622
(SPRY)
PF01547
(SBP_bac_1) 		5 LEU A 262
ILE A 108
VAL A  97
LEU A  76
ILE A  79
 None
 0.85A 2h42C-4b3nA:
undetectable		 2h42C-4b3nA:
18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c8g 2-C-METHYL-D-ERYTHRI
TOL
2,4-CYCLODIPHOSPHATE
SYNTHASE

(Burkholderia
cenocepacia) 		PF02542
(YgbB) 		5 LEU A  43
ALA A  45
ILE A  46
VAL A 100
ALA A 133
 None
None
None
None
C5P  A1163 (-3.6A)
 1.09A 2h42C-4c8gA:
undetectable		 2h42C-4c8gA:
18.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4edq MALTOSE-BINDING
PERIPLASMIC
PROTEIN,MYOSIN-BINDI
NG PROTEIN C,
CARDIAC-TYPE
CHIMERIC PROTEIN

(Escherichia
coli;
Mus musculus) 		PF07679
(I-set)
PF13416
(SBP_bac_8) 		5 LEU A 263
ILE A 109
VAL A  98
LEU A  77
ILE A  80
 None
 1.03A 2h42C-4edqA:
undetectable		 2h42C-4edqA:
19.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4egc MALTOSE-BINDING
PERIPLASMIC PROTEIN,
HOMEOBOX PROTEIN
SIX1 CHIMERA

(Escherichia
coli;
Homo sapiens) 		PF00046
(Homeobox)
PF13416
(SBP_bac_8)
PF16878
(SIX1_SD) 		5 LEU A 262
ILE A 108
VAL A  97
LEU A  76
ILE A  79
 None
 0.99A 2h42C-4egcA:
undetectable		 2h42C-4egcA:
21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4exk MALTOSE-BINDING
PERIPLASMIC PROTEIN,
UNCHARACTERIZED
PROTEIN CHIMERA

(Escherichia
coli;
Salmonella
enterica) 		PF13416
(SBP_bac_8)
PF16583
(ZirS_C) 		5 LEU A 262
ILE A 108
VAL A  97
LEU A  76
ILE A  79
 None
 1.09A 2h42C-4exkA:
undetectable		 2h42C-4exkA:
21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f55 SPORE CORTEX-LYTIC
ENZYME

(Bacillus cereus) 		PF07486
(Hydrolase_2) 		5 LEU A 217
ALA A 219
VAL A 154
ALA A 153
ILE A 190
 None
 0.95A 2h42C-4f55A:
undetectable		 2h42C-4f55A:
18.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f92 U5 SMALL NUCLEAR
RIBONUCLEOPROTEIN
200 KDA HELICASE

(Homo sapiens) 		PF00270
(DEAD)
PF00271
(Helicase_C)
PF02889
(Sec63) 		5 LEU B1320
LEU B1365
ALA B1363
ILE B1426
PHE B1397
 None
 0.85A 2h42C-4f92B:
undetectable		 2h42C-4f92B:
11.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fc2 POLY(ADP-RIBOSE)
GLYCOHYDROLASE

(Mus musculus) 		PF05028
(PARG_cat) 		5 ALA A 841
ILE A 817
VAL A 858
ALA A 859
ILE A 719
 None
 1.06A 2h42C-4fc2A:
undetectable		 2h42C-4fc2A:
19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fet SPORE CORTEX-LYTIC
ENZYME PREPEPTIDE

(Bacillus
anthracis) 		no annotation 5 LEU B 211
ALA B 213
ILE B 214
ALA B 147
ILE B 184
 None
 0.84A 2h42C-4fetB:
undetectable		 2h42C-4fetB:
20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fet SPORE CORTEX-LYTIC
ENZYME PREPEPTIDE

(Bacillus
anthracis) 		no annotation 5 LEU B 211
ALA B 213
VAL B 148
ALA B 147
ILE B 184
 None
 1.05A 2h42C-4fetB:
undetectable		 2h42C-4fetB:
20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fin ETTA (YJJK) ABCF
FAMILY PROTEIN

(Escherichia
coli) 		PF00005
(ABC_tran)
PF12848
(ABC_tran_Xtn) 		5 LEU A 230
ILE A  35
ALA A  53
ILE A  71
PHE A  29
 None
 1.00A 2h42C-4finA:
undetectable		 2h42C-4finA:
21.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g79 SPINDLE ASSEMBLY
ABNORMAL PROTEIN 6

(Caenorhabditis
elegans) 		PF16531
(SAS-6_N) 		5 LEU A  98
LEU A  36
ILE A  55
ILE A 108
PHE A 118
 None
 1.10A 2h42C-4g79A:
undetectable		 2h42C-4g79A:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gfa SPINDLE ASSEMBLY
ABNORMAL PROTEIN 6

(Caenorhabditis
elegans) 		PF16531
(SAS-6_N) 		5 LEU A  98
LEU A  36
ILE A  55
ILE A 108
PHE A 118
 None
 1.09A 2h42C-4gfaA:
undetectable		 2h42C-4gfaA:
20.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4giz MALTOSE-BINDING
PERIPLASMIC PROTEIN,
UBIQUITIN LIGASE
EA6P: CHIMERIC
PROTEIN

(Escherichia
coli;
Homo sapiens) 		PF01547
(SBP_bac_1) 		5 LEU A 263
ILE A 109
VAL A  98
LEU A  77
ILE A  80
 None
 0.97A 2h42C-4gizA:
undetectable		 2h42C-4gizA:
21.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hsu LYSINE-SPECIFIC
HISTONE DEMETHYLASE
1B

(Homo sapiens) 		PF01593
(Amino_oxidase)
PF04433
(SWIRM)
PF07496
(zf-CW) 		5 LEU A 632
ILE A 786
VAL A 623
ILE A 819
PHE A 792
 None
 1.13A 2h42C-4hsuA:
undetectable		 2h42C-4hsuA:
18.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4htz CGMP-DEPENDENT
3',5'-CYCLIC
PHOSPHODIESTERASE

(Homo sapiens) 		PF00233
(PDEase_I) 		7 TYR A 655
LEU A 770
LEU A 809
PHE A 830
ILE A 855
GLN A 859
PHE A 862
 None
 0.57A 2h42C-4htzA:
40.1		 2h42C-4htzA:
35.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4id0 GLUTATHIONE
S-TRANSFERASE-LIKE
PROTEIN YIBF

(Pseudomonas
fluorescens) 		PF13410
(GST_C_2)
PF13417
(GST_N_3) 		5 ALA A 146
ILE A 147
VAL A 161
ALA A 162
ILE A 191
 None
 0.77A 2h42C-4id0A:
undetectable		 2h42C-4id0A:
19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ikm MALTOSE-BINDING
PERIPLASMIC PROTEIN,
CASPASE RECRUITMENT
DOMAIN-CONTAINING
PROTEIN 8

(Escherichia
coli;
Homo sapiens) 		PF00619
(CARD)
PF13416
(SBP_bac_8) 		5 LEU A 263
ILE A 109
VAL A  98
LEU A  77
ILE A  80
 None
 0.94A 2h42C-4ikmA:
undetectable		 2h42C-4ikmA:
21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4irl MALTOSE-BINDING
PERIPLASMIC PROTEIN,
NOVEL PROTEIN
SIMILAR TO
VERTEBRATE GUANYLATE
BINDING PROTEIN
FAMILY

(Danio rerio;
Escherichia
coli) 		PF00619
(CARD)
PF13416
(SBP_bac_8) 		5 LEU A 263
ILE A 109
VAL A  98
LEU A  77
ILE A  80
 None
 1.10A 2h42C-4irlA:
undetectable		 2h42C-4irlA:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4kv3 CHIMERA FUSION
PROTEIN OF ESX-1
SECRETION SYSTEM
PROTEIN ECCD1 AND
MALTOSE-BINDING
PERIPLASMIC PROTEIN

(Escherichia
coli;
Mycobacterium
tuberculosis) 		PF08817
(YukD)
PF13416
(SBP_bac_8) 		5 LEU A 263
ILE A 109
VAL A  98
LEU A  77
ILE A  80
 None
 1.04A 2h42C-4kv3A:
undetectable		 2h42C-4kv3A:
19.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4li3 CYSTEINE SYNTHASE

(Haemophilus
influenzae) 		PF00291
(PALP) 		5 TYR X  79
ILE X  45
VAL X  80
ALA X  81
ILE X  65
 None
LLP  X  42 ( 4.0A)
None
None
None
 1.04A 2h42C-4li3X:
undetectable		 2h42C-4li3X:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4opm LIPASE

(Acinetobacter
baumannii) 		PF12697
(Abhydrolase_6) 		5 LEU A 262
VAL A  87
ALA A  88
LEU A  71
ILE A  99
 None
 0.95A 2h42C-4opmA:
undetectable		 2h42C-4opmA:
22.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4opm LIPASE

(Acinetobacter
baumannii) 		PF12697
(Abhydrolase_6) 		5 LEU A 264
VAL A  87
ALA A  88
LEU A  71
ILE A  99
 None
 1.11A 2h42C-4opmA:
undetectable		 2h42C-4opmA:
22.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4orb SERINE/THREONINE-PRO
TEIN PHOSPHATASE 2B
CATALYTIC SUBUNIT
ALPHA ISOFORM

(Mus musculus) 		PF00149
(Metallophos) 		5 LEU A 139
ALA A 135
ILE A 138
VAL A  34
ALA A  31
 None
 1.07A 2h42C-4orbA:
undetectable		 2h42C-4orbA:
22.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ozy POLY(BETA-D-MANNURON
ATE) C5 EPIMERASE

(Pseudomonas
syringae group
genomosp. 3) 		PF13229
(Beta_helix) 		5 LEU A 399
ILE A 343
ALA A 328
LEU A  75
ILE A 326
 None
 1.00A 2h42C-4ozyA:
undetectable		 2h42C-4ozyA:
19.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p5w CALCIUM-BINDING
MITOCHONDRIAL
CARRIER PROTEIN
ARALAR2,CALCIUM-BIND
ING MITOCHONDRIAL
CARRIER PROTEIN
ARALAR2

(Homo sapiens) 		no annotation 5 LEU A 195
LEU A 203
ALA A 205
ALA A 276
PHE A 223
 None
 0.76A 2h42C-4p5wA:
undetectable		 2h42C-4p5wA:
22.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pbv PROTEIN-TYROSINE
PHOSPHATASE
CRYPALPHA1 ISOFORM

(Gallus gallus) 		PF07679
(I-set)
PF13927
(Ig_3) 		5 LEU C  95
LEU C 121
ALA C 212
PHE C 133
LEU C 129
 None
 1.00A 2h42C-4pbvC:
undetectable		 2h42C-4pbvC:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pe2 MALTOSE ABC
TRANSPORTER
PERIPLASMIC
PROTEIN,PREPILIN-TYP
E N-TERMINAL
CLEAVAGE/METHYLATION
DOMAIN PROTEIN

(Clostridioides
difficile;
Escherichia
coli) 		PF13416
(SBP_bac_8) 		5 LEU A 262
ILE A 108
VAL A  97
LEU A  76
ILE A  79
 None
 0.96A 2h42C-4pe2A:
undetectable		 2h42C-4pe2A:
20.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pqk MALTOSE ABC
TRANSPORTER
PERIPLASMIC PROTEIN,
TRUNCATED
REPLICATION PROTEIN
REPA

(Escherichia
coli;
Staphylococcus
aureus) 		PF13416
(SBP_bac_8) 		5 LEU A 263
ILE A 109
VAL A  98
LEU A  77
ILE A  80
 None
 1.01A 2h42C-4pqkA:
undetectable		 2h42C-4pqkA:
21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q6t GLYCOSYL HYDROLASE,
FAMILY 18

(Pseudomonas
protegens) 		PF00704
(Glyco_hydro_18) 		5 LEU A 132
LEU A  67
ILE A 114
ALA A 158
PHE A 148
 None
 0.91A 2h42C-4q6tA:
undetectable		 2h42C-4q6tA:
20.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qvh MALTOSE-BINDING
PERIPLASMIC PROTEIN,
4'-PHOSPHOPANTETHEIN
YL TRANSFERASE
CHIMERA

(Escherichia
coli;
Mycobacterium
tuberculosis) 		PF01648
(ACPS)
PF13416
(SBP_bac_8) 		5 LEU A 263
ILE A 109
VAL A  98
LEU A  77
ILE A  80
 None
 1.08A 2h42C-4qvhA:
undetectable		 2h42C-4qvhA:
18.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rwf MALTOSE TRANSPORTER
SUBUNIT, RECEPTOR
ACTIVITY-MODIFYING
PROTEIN 2,
CALCITONIN
GENE-RELATED PEPTIDE
TYPE 1 RECEPTOR
FUSION PROTEIN

(Escherichia
coli;
Homo sapiens) 		PF02793
(HRM)
PF04901
(RAMP)
PF13416
(SBP_bac_8) 		5 LEU A 264
ILE A 110
VAL A  99
LEU A  78
ILE A  81
 None
 1.00A 2h42C-4rwfA:
undetectable		 2h42C-4rwfA:
20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tsm MALTOSE-BINDING
PROTEIN, PILIN
CHIMERA

(Clostridioides
difficile;
Escherichia
coli) 		PF13416
(SBP_bac_8) 		5 LEU A 262
ILE A 108
VAL A  97
LEU A  76
ILE A  79
 None
 0.97A 2h42C-4tsmA:
undetectable		 2h42C-4tsmA:
20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wzi CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B

(Homo sapiens) 		PF00233
(PDEase_I) 		5 TYR A 405
LEU A 565
PHE A 586
GLN A 615
PHE A 618
 None
 0.52A 2h42C-4wziA:
35.9		 2h42C-4wziA:
21.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4x6g OXYR

(Pseudomonas
aeruginosa) 		PF00126
(HTH_1)
PF03466
(LysR_substrate) 		5 LEU A 113
LEU A 122
ALA A 275
LEU A 160
ILE A 146
 None
 0.94A 2h42C-4x6gA:
undetectable		 2h42C-4x6gA:
19.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xuf RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 783
LEU A 788
ALA A 792
ILE A 881
VAL A 825
 None
 1.05A 2h42C-4xufA:
undetectable		 2h42C-4xufA:
21.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xuk PUTATIVE HYDROLASE

(Acinetobacter
sp. NBRC 100985) 		PF00753
(Lactamase_B) 		5 LEU A 116
ILE A 117
VAL A  61
ALA A  58
ILE A 260
 None
 1.02A 2h42C-4xukA:
undetectable		 2h42C-4xukA:
23.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y0m OXYR

(Pseudomonas
aeruginosa) 		PF03466
(LysR_substrate) 		5 LEU A 113
LEU A 122
ALA A 275
LEU A 160
ILE A 146
 None
 0.86A 2h42C-4y0mA:
undetectable		 2h42C-4y0mA:
20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4y5j MINI SPINDLES TOG3

(Drosophila
melanogaster) 		no annotation 5 LEU A 685
LEU A 698
ALA A 700
LEU A 653
ILE A 638
 None
 1.04A 2h42C-4y5jA:
undetectable		 2h42C-4y5jA:
20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5c7r FUSION PROTEIN OF
MALTOSE-BINDING
PERIPLASMIC PROTEIN
AND TYPE-3
ICE-STRUCTURING
PROTEIN HPLC 12

(Escherichia
coli;
Zoarces
americanus) 		PF01547
(SBP_bac_1) 		5 LEU A 262
ILE A 108
VAL A  97
LEU A  76
ILE A  79
 None
 0.98A 2h42C-5c7rA:
undetectable		 2h42C-5c7rA:
20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cwu NUCLEOPORIN NUP188

(Chaetomium
thermophilum) 		no annotation 5 LEU A1559
LEU A1515
ILE A1574
VAL A1580
LEU A1641
 None
None
GOL  A1901 (-4.6A)
None
None
 0.92A 2h42C-5cwuA:
undetectable		 2h42C-5cwuA:
21.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eqv BIFUNCTIONAL
2',3'-CYCLIC
NUCLEOTIDE
2'-PHOSPHODIESTERASE
/3'-NUCLEOTIDASE
PERIPLASMIC
PRECURSOR PROTEIN

(Yersinia pestis) 		PF00149
(Metallophos) 		5 LEU A 236
LEU A 288
ILE A 291
ALA A 213
ILE A 185
 None
 1.12A 2h42C-5eqvA:
undetectable		 2h42C-5eqvA:
22.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5h2r PHOSPHODIESTERASE

(Trypanosoma
brucei) 		no annotation 5 TYR A 668
VAL A 841
PHE A 845
GLN A 875
PHE A 878
 LLN  A1003 ( 4.8A)
LLN  A1003 (-4.6A)
LLN  A1003 (-4.6A)
LLN  A1003 (-3.0A)
LLN  A1003 (-3.8A)
 0.62A 2h42C-5h2rA:
37.5		 2h42C-5h2rA:
32.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h7n NLRP12-PYD WITH MBP
TAG

(Homo sapiens) 		PF02758
(PYRIN)
PF13416
(SBP_bac_8) 		5 LEU A 263
ILE A 109
VAL A  98
LEU A  77
ILE A  80
 None
 0.95A 2h42C-5h7nA:
undetectable		 2h42C-5h7nA:
21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hz7 COMP

(Neisseria
meningitidis) 		PF13416
(SBP_bac_8)
PF16732
(ComP_DUS) 		5 LEU A 263
ILE A 109
VAL A  98
LEU A  77
ILE A  80
 None
 1.09A 2h42C-5hz7A:
undetectable		 2h42C-5hz7A:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j3n GREEN FLUORESCENT
PROTEIN,HSDR

(Aequorea
victoria;
Escherichia
coli) 		PF01353
(GFP)
PF12008
(EcoR124_C) 		5 LEU A 363
LEU A 359
ALA A 352
ALA A 325
ILE A 398
 None
 1.10A 2h42C-5j3nA:
undetectable		 2h42C-5j3nA:
22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jcp ARF-GAP WITH RHO-GAP
DOMAIN, ANK REPEAT
AND PH
DOMAIN-CONTAINING
PROTEIN
3,LINKER,TRANSFORMIN
G PROTEIN RHOA

(Homo sapiens;
synthetic
construct) 		no annotation 5 LEU B 980
LEU B1034
ALA B1032
ILE B1035
LEU B 935
 None
 1.03A 2h42C-5jcpB:
undetectable		 2h42C-5jcpB:
22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jd0 ARF-GAP WITH RHO-GAP
DOMAIN, ANK REPEAT
AND PH
DOMAIN-CONTAINING
PROTEIN 3

(Homo sapiens) 		PF00620
(RhoGAP) 		5 LEU A 980
LEU A1034
ALA A1032
ILE A1035
LEU A 935
 None
 1.10A 2h42C-5jd0A:
undetectable		 2h42C-5jd0A:
19.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mwl INOSITOL-PENTAKISPHO
SPHATE 2-KINASE

(Mus musculus) 		PF06090
(Ins_P5_2-kin) 		5 LEU A 233
ILE A 217
ALA A 406
LEU A 429
ILE A 132
 None
 1.03A 2h42C-5mwlA:
undetectable		 2h42C-5mwlA:
22.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5oes GLUTATHIONE
SYNTHETASE

(Solanum
tuberosum) 		no annotation 5 VAL A  80
ALA A  81
PHE A  84
LEU A 154
ILE A 437
 None
 1.02A 2h42C-5oesA:
undetectable		 2h42C-5oesA:
13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ohj CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B

(Homo sapiens) 		no annotation 5 TYR A 405
LEU A 565
PHE A 586
GLN A 615
PHE A 618
 None
9VE  A 801 (-4.7A)
9VE  A 801 (-3.6A)
9VE  A 801 (-3.2A)
9VE  A 801 (-3.9A)
 0.56A 2h42C-5ohjA:
35.9		 2h42C-5ohjA:
13.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ttd MALTOSE-BINDING
PERIPLASMIC
PROTEIN,PILIN
ISOPEPTIDE LINKAGE
DOMAIN PROTEIN

(Escherichia
coli;
Streptococcus
pyogenes) 		PF12892
(FctA)
PF13416
(SBP_bac_8) 		5 LEU A 268
ILE A 114
VAL A 103
LEU A  82
ILE A  85
 None
 1.12A 2h42C-5ttdA:
undetectable		 2h42C-5ttdA:
19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ufl PROTEIN CIP2A

(Homo sapiens) 		no annotation 5 LEU A 288
LEU A 303
ALA A 305
VAL A 255
ILE A 238
 None
 1.01A 2h42C-5uflA:
undetectable		 2h42C-5uflA:
21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vaw MALTOSE-BINDING
PERIPLASMIC
PROTEIN,TYPE IV
PILIN PILA

(Acinetobacter
baumannii;
Escherichia
coli) 		no annotation 5 LEU A 262
ILE A 108
VAL A  97
LEU A  76
ILE A  79
 SER  A1205 (-3.9A)
None
None
None
None
 0.95A 2h42C-5vawA:
undetectable		 2h42C-5vawA:
15.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ve8 KAP123

(Kluyveromyces
lactis) 		no annotation 5 LEU A 869
LEU A 887
ILE A 890
ALA A 804
PHE A 861
 None
 0.99A 2h42C-5ve8A:
undetectable		 2h42C-5ve8A:
14.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wh6 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D

(Homo sapiens) 		no annotation 5 TYR A 159
LEU A 319
PHE A 340
GLN A 369
PHE A 372
 AKJ  A 601 ( 4.7A)
AKJ  A 601 ( 4.6A)
AKJ  A 601 (-4.5A)
AKJ  A 601 (-3.0A)
AKJ  A 601 (-4.1A)
 0.55A 2h42C-5wh6A:
36.0		 2h42C-5wh6A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wq6 MBP TAGGED HMNDA-PYD

(Homo sapiens) 		PF02758
(PYRIN)
PF13416
(SBP_bac_8) 		5 LEU A 263
ILE A 109
VAL A  98
LEU A  77
ILE A  80
 None
 1.08A 2h42C-5wq6A:
undetectable		 2h42C-5wq6A:
20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x03 HTH-TYPE
TRANSCRIPTIONAL
REGULATORY PROTEIN
GABR

(Bacillus
subtilis) 		PF00155
(Aminotran_1_2) 		5 LEU A 378
ILE A 379
VAL A 390
PHE A 405
PHE A 401
 None
 1.04A 2h42C-5x03A:
undetectable		 2h42C-5x03A:
22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5y37 GLYCERALDEHYDE-3-PHO
SPHATE DEHYDROGENASE

(Streptococcus
agalactiae) 		no annotation 5 TYR A 324
ALA A 126
ILE A 124
ALA A  21
ILE A  11
 NAD  A 401 (-3.6A)
NAD  A 401 (-3.3A)
None
None
None
 1.04A 2h42C-5y37A:
undetectable		 2h42C-5y37A:
13.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bnp UNCONVENTIONAL
MYOSIN-VI

(Sus scrofa) 		no annotation 5 LEU I 263
LEU I 251
ILE I 247
ALA I 424
LEU I 379
 None
 0.99A 2h42C-6bnpI:
undetectable		 2h42C-6bnpI:
12.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6guo -

(-) 		no annotation 5 LEU A 270
LEU A 174
ALA A 170
PHE A 297
LEU A 301
 None
 0.91A 2h42C-6guoA:
undetectable		 2h42C-6guoA:
undetectable